2025/04/20 更新

写真a

サトウ ヒロヤス
佐藤 裕康
SATO Hiroyasu
職名
助教

取得学位

  • 博士(医学),山形大学,2010年03月

 

論文

  • A novel TBK1 loss-of-function variant associated with ALS and parkinsonism phenotypes,Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration,2024年

    Hiroya Naruse 1 2, Chifumi Iseki 3 4, Jun Mitsui 1 2, Jun Miki 5, Hikaru Nagasawa 6, Katsuro Kurokawa 7, Ryota Kobayashi 8, Hiroyasu Sato 3, Jun Goto 9, Wataru Satake 1, Hiroyuki Ishiura 1 10, Shoji T...

    共著(国内のみ)

  • Anti-IgLON5 Disease Showing an Improvement in Dysautonomia, Including Vocal Cord Palsy, via Combined Immunotherapy,Internal medicine,2024年

    Daisuke Sato 1, Hiroyasu Sato 1, Toshiyuki Kondo 1, Ryosuke Igari 1, Chifumi Iseki 1, Hikaru Kawahara 1, Shintaro Amano 2, Yoya Ono 3, Akio Kimura 3, Takayoshi Shimohata 3, Yasuyuki Ohta 1

    共著(国内のみ)

  • Anti-IgLON5 disease as a differential diagnosis of multiple system atrophy.,Parkinsonism & Related Disorders,2024年

    Yoya Ono, Koh Tadokoro, Taijun Yunoki, Toru Yamashita, Daisuke Sato, Hiroyasu Sato, Shintaro Akamatsu, Heisuke Mizukami, Yasuyuki Ohta, Yoshihisa Yamano, Akio Kimura, Takayoshi Shimohata

    共著(国内のみ)

  • A Case with Anti-ganglioside Antibodies Showing Multiple Cranial Nerve Palsies Detected on Gadolinium-enhanced Magnetic Resonance Imaging,Intern Medicine,2023年

    Daisuke Suzuki 1, Shingo Koyama 1, Naomi Takahashi 1, Yuya Suzuki 1, Ryosuke Igari 1, Chifumi Iseki 1, Hiroyasu Sato 1, Toshitada Hiraka 2, Masafumi Kanoto 2, Yasuyuki Ohta 1

    共著(国内のみ)

  • Therapeutic effect of a novel curcumin derivative GT863 on a mouse model of amyotrophic lateral sclerosis,Therapeutic effect of a novel curcumin derivative GT863 on a mouse model of amyotrophic lateral sclerosis,2022年

    Hajime Kato 1 2, Hiroyasu Sato 1, Michiaki Okuda 3 4, Jun Wu 3, Shingo Koyama 1, Yasuhiko Izumi 3, Tomonori Waku 5, Mitsuyoshi Iino 2, Masashi Aoki 6, Shigeki Arawaka 1, Yasuyuki Ohta 1, Kenichi Ishiz...

    共著(国内のみ)

  • Prevalence and development of idiopathic normal pressure hydrocephalus: A 16-year longitudinal study in Japan,Acta Neurologica Scandinavica,2022年

    Chifumi Iseki 1, Yoshimi Takahashi 1, Michito Adachi 2, Ryosuke Igari 1, Hiroyasu Sato 1, Shingo Koyama 1, Kenichi Ishizawa 1, Yasuyuki Ohta 1, Takeo Kato 3

    共著(国内のみ)

  • Clinicopathologic Features of Oculopharyngodistal Myopathy With LRP12 CGG Repeat Expansions Compared With Other Oculopharyngodistal Myopathy Subtypes,JAMA Neurology,2021年

    Theerawat Kumutpongpanich, Masashi Ogasawara, Ayami Ozaki, Hiroyuki Ishiura, Shoji Tsuji, Narihiro Minami, Shinichiro Hayashi, Satoru Noguchi, Aritoshi Iida, Ichizo Nishino; OPDM_LRP12 Study Group; Ma...

    共著(国内のみ)

  • Monoamine Oxidase-B Inhibition Facilitates α-Synuclein Secretion In Vitro and Delays Its Aggregation in rAAV-Based Rat Models of Parkinson's Disease,Journal of Neuroscience,2021年

    Yoshitsugu Nakamura 1, Shigeki Arawaka 2, Hiroyasu Sato 3, Asuka Sasaki 3, Taro Shigekiyo 1, Kazue Takahata 4, Hiroko Tsunekawa 4, Takeo Kato 3

    共著(国内のみ)

  • Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates.,Acta Neuropathologica Communications,2017年06月

    Shigeki Arawaka, Hiroyasu Sato, Asuka Sasaki, Shingo Koyama and Takeo Kato

    共著(国内のみ)

  • Zonisamide attenuates α-synuclein neurotoxicity by an aggregation-independent mechanism in a rat model of familial Parkinson's disease.,PloS One,2014年02月

    Arawaka S, Fukushima S, Sato H, Sasaki A, Koga K, Koyama S, Kato T

    共著(海外含む)

  • Lymphomatosis cerebri with intramedullary spinal cord involvement.,Internal Medicine,2013年

    Sato H, Takahashi Y, Wada M, Shiono Y, Suzuki I, Kohno K, Kato Y, Kawanami T, Sakurada K, Kayama T, Kato T

    共著(海外含む)

  • Authentically phosphorylated α-synuclein at Ser129 accelerates neurodegeneration in a rat model of familial Parkinson's disease.,Journal of Neuroscience,2011年11月

    Sato H, Arawaka S, Hara S, Fukushima S, Koga K, Koyama S, Kato T

    共著(海外含む)

全件表示 >>

総説・解説記事

  • Potential of Cellular and Animal Models Based on a Prion-Like Propagation of α-Synuclein for Assessing Antiparkinson Agents.,Molecular Neurobiology,2015年08月

    Sato H, Kato T, Arawaka S

  • The role of Ser129 phosphorylation of α-synuclein in neurodegeneration of Parkinson's disease: a review of in vivo models.,Reviews in the Neurosciences,2013年04月

    Sato H, Kato T, Arawaka S

科研費(文科省・学振)獲得実績

  • 基盤研究(C),2022年04月 ~ 2025年03月,α-synuclein神経毒性に対するアデノシンA2a受容体阻害の神経保護効果

    神経内科学関連

  • 基盤研究(C),2018年04月 ~ 2021年03月,PLK2ノックアウトによるSer129リン酸化αシヌクレイン神経毒性の解明

    病態神経科学関連